JianCong Liu

JianCong Liu has extensive work experience in the biopharmaceutical industry. JianCong started their career at Pfizer as an Associate Scientist in 2004 and later worked at Biogen as an Associate Medical Director from 2006 to 2008. JianCong then joined ARIAD Pharmaceuticals, Inc. as a Medical Director from 2008 to 2011. JianCong subsequently moved to Takeda Oncology and held the role of Global Clinical Lead/Senior Medical Director from 2011 to 2014. In this role, they led the global clinical development for lung cancer assets, including the clinical trial execution of EXKIVITY™ (mobocertinib). JianCong also developed strategic directions for interactions with regulatory agencies and authored key clinical and regulatory documents. Since 2015, JianCong has been with Ansun Biopharma, Inc. as the SVP of Clinical Development.

JianCong Liu holds a Master of Science degree in Toxicology from Peking University. JianCong also earned a Doctor of Philosophy degree in Pharmacokinetics and Pharmacogenomics from the University of California, San Francisco.